"Serving the community with advanced, high-quality GI, liver, and therapeutic endoscopy services."

During the past decade, Kansas City Gastroenterology and Hepatology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 12 clinical trials were completed, i.e. on average, 240% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kansas City Gastroenterology and Hepatology" #1 sponsor was "Gilead Sciences" with 11 trials, followed by "Abbott" with 3 trials sponsored, "Evoke Pharma" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Astellas Pharma Inc" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kansas City Gastroenterology and Hepatology" #1 collaborator was "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Kansas City Gastroenterology and Hepatology" are "Chronic Hepatitis C" (4 trials), "Crohn's Disease" (4 trials), "Diabetic Gastroparesis" (3 trials), "Hepatitis C" (3 trials) and "Hepatitis B" (2 trials). Many other conditions were trialed in "Kansas City Gastroenterology and Hepatology" in a lesser frequency.

Most popular intervention types in "Kansas City Gastroenterology and Hepatology" are "Drug" (21 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "RBV" (5 trials), "SOF" (3 trials), "placebo" (3 trials), "Metoclopramide Nasal Spray" (2 trials) and "PEG" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kansas City Gastroenterology and Hepatology" are 23 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kansas City Gastroenterology and Hepatology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Kansas City Gastroenterology and Hepatology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Kansas City Gastroenterology and Hepatology, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".